Insights

Most B2B companies don't have a growth problem. They have an architecture problem.

Oliver Lopez — Mon, 12 Oct 2026 10:14:33 GMT

When a founder tells me they have a growth problem, I've learned to translate. Nine times out of ten, growth is the symptom they can measure, the pipeline that went flat, the quarter that missed, the new rep who isn't ramping. What they actually have is an architecture problem. The revenue is leaking through joints that were never engineered to hold pressure, and no amount of additional volume poured in at the top fixes a structure that leaks at the seams.

Your CRM is not a strategy.

Oliver Lopez — Mon, 12 Oct 2026 10:14:17 GMT

When the pipeline feels unpredictable, the reflex is to reach for the tool. The CRM is old, the reports are a mess, the data is dirty, so the company launches a re-platforming project and waits for clarity to arrive. It rarely does. A year and a large invoice later, the same questions have no better answers, because the problem was never the software. A CRM is a system of record. It remembers your process. It cannot invent one.

Disqualification is a growth lever, not a loss.

Oliver Lopez — Mon, 12 Oct 2026 10:14:00 GMT

One of the hardest things to sell a founder is the idea that their pipeline should be smaller. Every instinct of a growth-stage company points the other way. More logos, more opportunities, more coverage, pipeline is the thing you've been told to build. So when a diagnosis comes back saying that a third of the pipeline is matched to the wrong customer and should be actively killed, the room goes quiet.

From founder-led to forecastable.

Oliver Lopez — Mon, 12 Oct 2026 10:13:44 GMT

There's a moment in most scaleups when the forecast stops being believable. It usually arrives around the time a board does. For a while, the founder's gut was the forecast, and the gut was right often enough that nobody questioned it. Then the numbers get bigger, the deals get more numerous, and "I think we'll land most of these" stops being an acceptable answer to a director who's about to underwrite a hiring plan against it.

Fractional CRO or commercial architecture?

Oliver Lopez — Mon, 12 Oct 2026 10:13:28 GMT

When the number flattens, two kinds of help get recommended, and they are often confused. One is a fractional CRO: an experienced revenue leader who steps in part-time to run your sales organisation. The other is commercial architecture: the work of designing the system that produces revenue and handing it to your team. They sound adjacent. They are not, and buying them in the wrong order is expensive.

How to stress test your go-to-market.

Oliver Lopez — Mon, 12 Oct 2026 10:13:01 GMT

Banks do not ask whether they feel solid. They model a shock, a rate spike, a run of defaults, and see what breaks first. A go-to-market stress test does the same thing to the system that produces your revenue. It is not an audit of activity and it is not a health check. It is a deliberate search for the point where the commercial system fails under pressure, run before the market applies the pressure for you.

Messaging that survives a skeptical buyer.

Oliver Lopez — Mon, 12 Oct 2026 10:12:44 GMT

Most companies test their messaging on exactly the wrong audience. The pitch gets refined in front of warm intros, existing customers and people who already like the founder, and it performs beautifully, because that audience was going to nod anyway. Then it meets a real buyer, someone with a budget, a shortlist and a healthy reason to doubt, and it dissolves. The messaging was never wrong so much as never tested.

The MQL-to-SQL handoff is a fiction nobody believes.

Oliver Lopez — Mon, 12 Oct 2026 10:12:28 GMT

Walk into almost any B2B company between two and twenty million in revenue and you'll find the same quiet stand-off. Marketing reports that it hit its MQL number. Sales reports that the leads were junk. Both are looking at the same dashboard. Both are, in their own frame, telling the truth. And the handoff between them, the MQL becoming an SQL, the moment a marketing lead becomes a sales opportunity, is a piece of theatre that everyone performs and no one believes.

Why your B2B sales stopped scaling.

Oliver Lopez — Mon, 12 Oct 2026 10:12:12 GMT

There is a particular quiet that settles over a B2B company somewhere between two and twenty million in revenue. The early growth was real. It came from a founder who could walk into any room and explain, in their own words, why this product mattered to that buyer. Then the curve flattens, and the reflex is to add: more reps, more tools, more pipeline. The additions produce activity and very little slope.

Handling customers about to churn, or already gone.

Emelie Svedberg — Mon, 12 Oct 2026 10:11:55 GMT

Every churn feels sudden from the inside. A renewal that looked safe goes quiet, an email arrives with the word "unfortunately" in it, and an account that was fine last quarter is gone. It feels like an event. It almost never is. By the time a customer tells you they are leaving, the decision is old news, made weeks earlier in a series of small moments nobody was watching.